 Biomerica Inc. NASDAQ: BMRA today announced they have signed definitive agreements with Mayo Clinic to join the clinical trial for Biomericas new InFoods diagnostic-guided therapy DGT, designed to alleviate Irritable Bowel Syndrome IBS symptoms. Mayo Clinic is joining Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, Houston Methodist and the University of Michigan as primary enrollment centers for this study. 